Privacy e cookie policy clicca qui

Accetta

Peer review 2009

  1. Agnelli L, Mosca L, Fabris S, Lionetti M, Andronache A, Kwee I, Todoerti K, Verdelli D, Battaglia C, Bertoni F, Lambertenghi Deliliers G, Neri A. 2009. A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect. Genes Chromosomes and Cancer 48, no. 7 (July): 603-614.
     

  2. Alerci M, Oberson M, Fogliata A, Gallino A, Vock P, Wyttenbach R. 2009. Prospective, intraindividual comparison of MRI versus MDCT for endoliea detection after endovascular repair of abdominal aortic aneurysms. Eur Radiol 19, no 5 (May): 1223-1231.
     

  3. Bellini C, Keiser O, Chave J-P, Evison JM, Fehr J, Kaiser L, Weber R, Vernazza P, Bernasconi E, Telenti A, Cavassini M and the Swiss HIV Cohort Study. 2009. Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: The Swiss HIV Cohort Study. HIV Med 10, no. 1 (January): 12-18.
     

  4. Benninger DH, Thees S, Kollias SS, Bassetti CL, Waldvgel D. 2009. Morphological differences in Parkinson’s disease with and without rest tremor. Journal of Neurology 256, no. 2 (February): 256-263.
     

  5. Bergmann M, Corigliano T, Ataia I, Renella R, Simonetti GD, Bianchetti MG, von Vigier RO. 2009. Childhood extraordinary daytime urinary frequency - a case series and a systematic literature review. Pediatr Nephrol 24, no. 4 (April): 789-795.
     

  6. Bielsa I, Soria X, Esteve M, Ferrándiz C, Skin Cancer Study Group of Barcelonès Nord (Mangas C). 2009. Population-based incidence of basal cell carcinoma in a Spanish Mediterranean area. Br J Dermatol 161, no. 6 (December): 1341-1346.
     

  7. Bomben R, Dal-Bo M, Capello D, Forconi F, Maffei R, Laurenti L, Rossi D, Del-Principe MI, Zucchetto A, Bertoni F, Rossi, FM, Bulian B, Cattarossi I, Ilariucci F, Sozzi E, Spina V, Zucca E, Degan D, Lauria F, Del-Poeta G, Efremov DG, Marasca R, Gaidano G, Gattei VG. 2009. Molecular and clinical features of chronic lymphocytic leukemia with stereotyped B cell receptors: results from an Italian multicenter study. British Journal Haematology 114, no. 4 (February): 492-506.
     

  8. Boy M, Tshibanda L, Vanhaudenhuyse A, Noirhomme Q, Schnakers C, Ledoux D, Boveroux P, Garweg C, Lambermont B, Philipps C, Luxen A, Moonen G, Bassetti C, Maquet P, Laureys S. 2009. Functional connectivity in the default network  during resting state is preserved in a vegetative but not in a brain dead patient. Hum Brain Mapp 30, no. 8 (August): 2393-2340.
     

  9. Brioschi A, Gramigna S, Werth E, Staub F, Ruffieux C, Bassetti C, Schluep M, Annoni JM. 2009. Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients. European Neurology  62 (4): 243-249.
     

  10. Candrian C, Barbero A, Bonacina E, Heberer M, Martin I. 2009. A novel implantation technique for engineered osteo-chondral grafts. Knee Surg Sports Traumatol Arthrosc 17, no. 11 (November): 1377-1383.
     
  11. Candrian C, Bonacina E, Frueh JA, Vonwil D, Dickinson S, Wirz D, Hebererer M, Jakob M, Martin I, Barbero A. 2009. Intra-individual comparison of human ankle and knee chondrocytes in vitro: relevance for talar cartilage repair. Osteoarthritis Cartilage 17, no. 4 (April): 489-496.
     
  12. Cereda C, Berger M, Rossetti AO. 2009. Bowel ischemia: a rare thiopental-related complication in refractory status epilepticus. Neurocritical Care 10 (3): 355-358.
     
  13. Cheng E, Duran I, Berthold DR, Moore MJ. 2009. Arterial thrombosis after cisplatin-based chemotherapy for metastatic germ cell tumors. Acta Oncol 48 (3): 475-477.
     
  14. Colleoni M; Bagnardi V; Rotmensz N; Gelber RD; Viale G; Pruneri G; Veronesi P; Torrisi R; Cardillo A; Montagna E; Campagnoli E; Luini A; Intra M; Galimberti V; Scarano E; Peruzzotti G; Goldhirsch A. 2009. Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy. Breast Cancer Res Treat 116, no. 2 (July): 359-369.
     

  15. Combescure C, Vallier N, Ledergerber B, Cavassini M, Furrer H, Rauch A, Battegay M, Bernasconi E, Vernazza P, Hirschel B and the Swiss HIV Cohort Study. 2009. How reliable is an undetectable viral load? HIV Med 10, no. 8 (September): 470-476.
     

  16. Compagno M, Lim WK, Grunn A, Nandula SV, Bertoni F, Ponzoni M, Scandurra M, Califano A, Bhagat G, Chadburn A, Dalla Favera R, Pasqualucci L. 2009. Mutations at multiple genes cause deregulation of the NF-kB pathway in diffuse large B-cell lymphoma. Nature 459, no. 7247 (June): 717-721.
     

  17. Conen A, Fehr J, Glass TR, Furrer H, Weber R, Vernazza P, Hirschel B, Cavassini M, Bernasconi E, Bucher HC, Battegay M and the Swiss HIV Cohort Study. 2009. Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study. Antiviral Therapy 14 (3): 349-357.

      

  18. Dal-Bo M, Bertoni F, Forconi F, Zucchetto A, Bomben R, Marasca R, Deaglio S, Laurenti L, Efremov DG, Gaidano G, Del Poeta G, Gattei V. Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance. Journal of Translational Medicine 7, no. 76 (August).
     

  19. De Dosso S, Mazzucchelli L, Ghielmini M, Saletti P. 2009. Response to oxaliplatin with cetuximab in minor salivary gland adenoid cystic carcinoma. Tumori 95, no. 3 (May-June): 378-381.

     
  20. De Dosso S, Sessa C, Saletti P. 2009. Adjuvant therapy for colon cancer: present and perspectives. Cancer Treat Rev 35, no. 2 (April): 160-166.
     
  21. Delmonte A, Ghielmini M, Sessa C. 2009. Beyond monoclonal antibodies: new therapeutic agents in non-Hodgkin's lymphomas. Oncologist 14, no. 5 (May): 511-525.
     
  22. Delmonte A, Sessa C. 2009. AVE8062: a new combretastatin derivative vascular disrupting agent. Expert Opin Investig Drugs 18, no. 10 (October): 1541-1548.
     
  23. Donghi D, Mainetti C. 2009. Infliximab for the Treatment of Refractory Adamantiades-Behçet Disease with Articular, Intestinal, Cerebral and Ocular Involvement. Dermatology 220 (3): 282-286.
     

  24. Elzi L, Kaufmann G, Weber R, Fux CA, Cavassini M, Hirschel B, Vernazza P, Bernasconi E, Battegay M and the Swiss HIV Cohort Study. 2009. Discontinuation of Enfuvirtide in heavily pretreated HIV-infected individuals. HIV Clin Trials 10, no. 4 (July - August): 207-214.
     

  25. Engelberger S, Schuld J, Schilling MK, Kollmar O. 2009. Cholecystocolonic fistula prevents upper intestinal obstruction by a large gallstone after perforation into the duodenum. Langenbecks Arch Surg 395, no. 1 (January): 95-97.

  26. Falesi M, Regazzoni BM, Wyttenbach M, Wyttenbach R, Bianchetti MG, Riavis M. 2009. Primary pelvic pyomyositis in a neonate. J Perinatol 29, no. 12 (December): 830-831.
     

  27. Ferrarini A, Ramelli GP, Bianchetti MG. 2009. Index of suspicion: oculo-cerebro-renal syndrome of Lowe. Pediatr Rev 30: 479-485.
     

  28. Ferreri AJ, Reni M, Foppoli M, Martelli M, Pangalis GA, Frezzato M, Cabras MG, Fabbri A, Corazzelli G, Iliarucci F, Rossi G, Soffietti R, Stelitano C, Vallisa D, Zaja F, Zoppegno L, Aondio GM, Avvisati G, Balzarotti M, Brandes AA, Fajardo J, Gomez H, Guarini A, Pinotti G, Rigacci L, Uhlmann C,m Picozzi P, Vezzulli P, Ponzoni M, Zucca E, Caligaris-Cappio F, Cavalli F; International Extranodal Lymphoma Study Group (IELSG). 2009. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. Lancet 374, no. 9700 (October):1512-1520.
     
  29. Feuerlein K, Zucca E, Ghielmini M. 2009. First-line treatment of follicular lymphoma: a patient-oriented algorithm. Leuk Lymphoma 50, no. 3 (March): 325-334.
     
  30. Fioole B, Van De Rest H J, Meijer J R, Van Leersum M, Van Koeverden S, Moll F L, van den Berg JC, De Vries J P M. 2009. Percutaneous transluminal angioplasty and stenting as first-choice treatment in patients with chronic mesenteric ischemia. J Vasc Surg 51, no. 2 (February): 391.
     
  31. Forconi F, Sozzi E, Cencini E, Zaja F, Intermesoli T, Stelitano C, Rigacci L, Gherlinzoni F, Cantaffa R, Baraldi A, Gallamini A, Zaccaria A, Pulsoni A, Gobbi M, Tassi M, Raspadori D, Leoncini L, Rinaldi A, Sabattini E, Bertoni F,  Pileri S, Lauria F. 2009. Hairy cell leukemias (HCL) with unmutated IgHV genes define the minor subset refractory to single agent Cladribine and with more aggressive behavior. Blood 114, no. 21 (November): 4696-4702.
     
  32. Fusetti C, Garavaglia G, Petri J, Lucchina S. 2009. A reliable and simple solution for recalcitrant carpal tunnel syndrome: the hypothenar fat pad flap. Am J Orthop 38, no. 4 (April): 181-186.
     
  33. Gabutti L, Bianchi G, Soldini D, Marone C, Burnier M. 2009. Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids. Nephrol Dial Transplant 24, no. 3 (March): 973-981.
     
  34. Gabutti L, Lucchini B, Marone C, Alberio L, Burnier M. 2009. Citrate- vs. acetate-based dialysate in bicarbonate haemodialyisis: conseguences on haemodynamics, coagulation, acid-base status, and electrolytes. BMC Nephrol 5: 10-17.
     
  35. Moccetti M, Wyttenbach R, Santini P, Corti R, Gallino A. 2009. Posttraumatic cardiac contre-coup: in vivo evidence by cardiac MRI. Circulation 119, no. 11 (March): 1538-1540.
     
  36. Garzoni L, Vanoni F, Rizzi M, Simonetti GD, Simonetti BG, Ramelli GP, Bianchetti MG. 2009. Nervous system dysfunction in Henoch-Schonlein syndrome: systematic review of the literature. Rheumatology 48, no. 12 (December): 1524-1529.
     
  37. Gentilini O, Botteri E, Rotmensz, Da Lima L, Caliskan M, Garcia-Etienne CA, Sosnoviskikh I, Intra M, Mazzarol G, Musmeci S, Veronesi P, Galimberti V, Luini A, Viale G, Goldhirsch A, Veronesi U. 2009. Conservative surgery in patients with multifocal/multicentric breast cancer. Breast Cancer Res Treat 113, no. 3 (February): 577-583.
     
  38. Ghielmini M, Zucca E. 2009. How I treat mantle cell lymphoma. Blood 114, no. 8 (August): 1469-1476.
     

  39. Ghielmini M, Zucca E. 2009. Response: CNS prophylaxis in MCL. Blood 114, no. 26 (December): 5403-5404.

     
  40. Giovanella L. 2009. False-negative thyroglobulin measurement in recurrent/metastatic thyroid carcinomas. Eur J Nucl Med Mol Imaging 36, no. 2 (February): 326-327.
     

  41. Giovanella L, Ceriani L, Suriano S, Crippa S. 2009. Thyroglobulin measurement on fine-needle washout fluids: influence of sample collection methods. Diagn Cytopathol 37, no. 1 (January): 42-44.

     
  42. Giovanella L, Keller F, Ceriani L, Tozzoli R. 2009. Heterophile antibodies may falsely increase or decrease thyroglobulin measurement in patients with differentiated thyroid carcinoma. Clin Chem Lab Med 47 (8): 952-954.
     

  43. Giovanella L, Maffioli M, Ceriani L, De Palma D, Spriano G. 2009. Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma. Clin Chem Lab Med 47 (8): 1001-1004.

     
  44. Giovanella L, Suriano S, Ceriani L. 2009. Decline in thyroid (18) fluorodeoxyglucose uptake associated with selenium supplementation in a patient with autoimmune Thyroiditis. Thyroid 19, no. 11 (November): 1291-1292.
     
  45. Hancock BW, Qian W, Linch D, Delchier JC, Smith P, Jakupovic I, Burton C, Souhami R, Wotherspoon A, Copie-Bergman C, Capella C, Traulle C, Levy M, Cortelazzo S, Ferreri AJ, Ambrosetti A, Pinotti G, Martinelli G, Vitolo U, Cavalli F, Gisselbrecht C, Zucca E. 2009. Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial. Br J Haematol. 144, no. 3 (February): 367-75.
     

  46. Herrlinger U, Glantz M, Schlegel U, Gisselbrecht C, Cavalli F. 2009. Should intra-cerebrospinal fluid prophiylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out more. Semin Oncol 36, no. 4 suppl. 2 (August): S25-34.
     

  47. Hermann DM, Barth A, Porchet F, Hess CW, Mumenthaler M, Bassetti CL. 2009. Nocturnal positional lumboischialgia: Presenting symptom of lumbar spinal tumors. Journal of Neurology 255, no. 11 (November): 1836-1837.

  48. Hermann DM, Bassetti CL. 2009. Sleep-related breathing and sleep-wake disturbances in ischemic stroke. Neurology 73, no. 16 (October): 1313-1322.
     

  49. Hermann D, Jung HH, Bassetti CL. 2009. Lateral medullary infarct with an alternating and dissociated sensorimotor deficits: Opalski's syndrome revisited. Eur Journal of Neurology 16, no. 4 (April): 72-74.

  50. Hilari JM, Mangas C, Xi L, Paradelo C, Ferrándiz C, Hughes SJ, Yueh C, Altomare I, Gooding WE, Godfrey TE. 2009. Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time rt-PCR. Ann Surg Oncol 16, no. 1 (January): 177-185.

     
  51. Hitz F, Martinelli G, Zucca E, von Moos R, Mingrone W, Simcock M, Peterson J, Cogliatti SB, Bertoni F, Zimmermann DR, Ghielmini M. 2009. A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03. Hematol Oncol 27, no. 3 (September): 154-159.
     

  52. Kallweit U, Siccoli MM, Poryazova R, Werth E, Bassetti CL. 2009. Excessive daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment. Eur Journal of Neurology 62 (3): 176-179.
     

  53. Keiser O, Spoerri A, Brinkhof MWG, Hasse B, Gayet-Ageron A, Tissot F, Christen A, Battegay M, Schmid P, Bernasconi E, Egger M. 2009. Suicide in HIV-infected individuals and the general population in Switzerland, 1988-2008. Am J Psychiatry 167, no. 2 (February): 143-150.
     

  54. Khanna N, Elzi L, Mueller NJ, Garzoni C, Cavassini M, Fux CA, Vernazza P, Bernasconi E, Battegay M, Hirsch HH for the Swiss HIV Cohort Study. 2009. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clin Infect Dis 48, no. 10 (May): 1459-1466.
     

  55. La Rosa S, Imperatori A, Giovanella L, Garancini S, Capella C. 2009. Thyroid metastases from typical carcinoid of the lung differentiating between medullary thyroid carcinoma and neuroendocrine tumor metastasis to the thyroid. Thyroid 19, no. 5 (May): 521-526.
     

  56. Laetsch Semadeni B, Mainetti C, Itin P, Lautenschlager S. 2009. Precalcaneal Congenital Fibrolipomatous Hamartomas: Report of 3 Additional Cases and Discussion of the Differential Diagnosis. Dermatology 218, no. 3 (January): 260-264.

     

  57. Lerch E, Espeli V, Zucca E, Leoncini L, Scali G, Mora O, Bordoni A, Cavalli F, Ghielmini M. 2009. Prognosis of acute myeloid leukemia in the general population: data from southern Switzerland. Tumori 95, no. 3 (May-June): 303-310.
     

  58. Leumann A, Wiewiorskki M, Egelhof T, Rasch H, Magerkurth O, Candrian C, Schaefer D J, Martin I, Jakob M, Valderrabano V. 2009. Radiographic evaluation of frontal talar edge configuration for osteochondralplug transplantation. Clin Anat 22, no. 2 (March): 261-266.

     
  59. Macdonald S, Lee R, Williams R, Stansby G; Delphi Carotid Stenting Consensus Panel (van den Berg JC member of panel). 2009. Towards safer carotid artery stenting-a scoring system for anatomic suitability. Stroke 40, no. 5 (May): 1698-1703.
     
  60. Martinelli G, Gigli F, Calabrese L, Ferrucci PF, Zucca E, Crosta C, Pruneri G, Preda L, Piperno G, Gospodarowicz M, Cavalli F, Gomez H. 2009. Early stage gastric diffuse large B-cell lymphomas: results of a randomised trial comparing chemotherapy alone versus chemotherapy + involved field radiotherapy. (IELSG 5).[corrected]. Leuk Lymphoma 50, no. 6 (June):925-931.
     

  61. Martinelli G, Ryan G, Seymour JF, Nassi L, Steffanoni S, Alietti A, Calabrese L, Pruneri G, Santoro L, Kuper-Hommel M, Tsang R, Zinzani PL, Taghian A, Zucca E, Cavalli F. 2009. Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group. Ann Oncol 20, no. 12 (December): 1993-1999. 

     
  62. Micheli A, Sanz N, Mwangi-Powell F, Coleman MP, Neal C, Ullrich A, Travado L, Santini LA, Grassi L, De Lorenzo F, Costa A, Dangou JM, Bisanti L, Seniori Costantini A, Abu-Rmeileh N, Kamal M, Federicoi M, Saracci G, Rennert G, Stefanini A, Cavalli F, Cazap E, Redmond K, O’Reilly S, Muti P, Casali P, Gatta G, Ferrari A, Koifman S, Bah E, Pastore G, Barr R, Lombardo C, Frazzingaro C, Ciampichini R, Baili P; ICCC-3 Session B Group. 2002. International collaborations in cancer control and the Third International Cancer Control Congress. Tumori 95, no. 5 (September-October): 579-596.
     
  63. Milani G, Fossali EF, Bianchetti MG. 2009. Diagnosis and surgical treatment of nutcracker syndrome: a single-center experience. Urology 74, no. 2 (August): 476-477.
     
  64. Miot S, Gianni-Barrera R, Pelttari K, Acharya C, Mainil-Varlet P, Juelke H, Jaquery C, Candrian C, Barbero A, Martin I. 2009. In vitro and in vivo validation of human and goat chondrocyte labeling by GFP lentivirus transduction. Tissue Engineering Part C Methods 16, no. 1 (February): 11-21.
     
  65. Molinari F, Martin V, Saletti P, De Dosso S, Spitale A, Camponovo A, Bordoni A, Crippa S, Mazzucchelli L, Frattini M. 2009. Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant. Br J Cancer 100, no. 7 (April): 1087-1094.
     

  66. Novak U, Rinaldi A, Kwee I, Nandula SV, Rancoita PM, Compagno M, Cerri M, Rossi D, Murty VV, Zucca E, Gaidano G, Dalla-Favera R, Pasqualucci L, Bhagat G, Bertoni F. 2009. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. Blood 113, no. 20 (May): 4918-4921.

     
  67. Oberson M, Zucca E, Mazzucchelli L, Menafoglio A, Guerra A, Gallino A. 2009. Extrinsic compression of the pulmonary artery by primary mediastinal large B-cell lymphoma. Br J Haematol 144, no. 3 (February): 277.
     
  68. Opravil M, Klimkait T, Louvel S, Wolf E, Battegay M, Fux Ch, Bernasconi E, Vogel M, Speck R, Weber R and the Swiss HIV Cohort Study. 2009. Prior therapy influences the efficacy of lamivudine monotherapy in patients with lamivudine-resistant HIV-1 infection. JAIDS 54, no. 1 (May): 51-58.
     
  69. Ortmann O, Cufer T, Dixon JM, Maass N, Marchetti P, Pagani O, Pronzato P, Semiglazov V, Spano JP, Vrdoljak E, Wildiers H. 2009. Adjuvant endocrine therapy for perimenopausal women with early breast cancer. Breast 18, no. 1 (February): 2-7.
     
  70. Pagani O, Gelber S, Simoncini E, Castiglione-Gertsch M, Price KN, Gelber RD, Holomberg SB, Crivellari D, Collins J, Lindtner J, Thürlimann B, Fey MF, Murray E, Frorbes JF, Coates AS, Goldhirsch A. IBCSG. 2009. Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93. Breast Cancer Res Treat 116, no. 3 (August): 491-500.
     
  71. Payoux P, Remy P, Miloudi M, Houeto JL, Stadler C, Bejjani BP, Yelnik J, Samson Y, Rascol O, Agid Y, Damier P. 2009. Contrasting changes in cortical activation induced by acute high-frequency stimulation within the globus pallidus in Parkinson's disease. Journal of Cerebral Blood Flow & Metabolism 29, no. 2 (February): 235-243.
     

  72. Peccatori FA, Azim HA Jr, Scarfone G, Gadducci A, Bonazzi C, Gentilini O, Galimberti V, Intra M, Locatelli M, Acaia B, Rossi P, Cineri S, Calabrese S, Goldhirsch A. 2009. Weekly epirubicin in the treatment of gestational breast cancer (GBC). Breast Cancer Res Treat 115, no. 3 (January): 591-594.
     

  73. Perotti A, Sessa C, Mancuso A, Noberasco C, Cresta S, Locatelli Al, Carcangiu M L, Passera K, Braghetti A, Scaramuzza D, Zanaboni F, Fasolo A, Capri G, Miani M, Peters W P, and Gianni L. 2009. Clinical and pharmacological phase I evaluation of Exherin (ADH-1), a  selective anti n-cadherin peptide in patients with n-cadherin expressing  solid tumours. Ann Oncol 20, no. 4 (April): 741-745.
     

  74. Perren A, Cerutti B, Lazzaro M, Donghi D, Previsdomini M, Marone C. Comparison of in-hospital secondary prophylaxis for different vascular diseases. Eur J Intern Med 20, no. 6(October): 631-635.
     

  75. Perren A, Donghi D, Marone C, Cerutti B. 2009. Economic burden of unjustified discharge medications. Swiss Med Wkly 139, no. 29-30 (July): 430-435.
     

  76. Perren A, Previsdomini M, Cerutti B, Soldini D, Donghi D, Marone C. 2009. Omitted and unjustified medications in the discharge summary. Qual Saf Health Care 18, no. 3 (June): 205-208.
     

  77. Pevernagie D, Stanley N, Berg S, Kriger J, Amici R, Bassetti C. 2009. European guidelines for the certification of professionals in sleep medicine: Report of the task force of the European Sleep Research Society. J Sleep Res 18, no. 1 (March): 136-141.
     

  78. Pizza F, Biallas M, Wolf M, Valko PO, Bassetti CL. 2009. Periodic leg movements during sleep and cerebral hemodynamic changes detected by NIRS. Clin Neurophysiol 120, no. 7(July): 1329-1334.
     

  79. Poryazova R, Khatami R, Werth E, Bassetti CL. 2009. Weak with sex-Sexual intercourse as a trigger for cataplexy. J Sexual Med 6, no. 8 (August): 2271-2277.
     

  80. Poryazova R, Schnepf B, Werth E, Khatamai R, Dydak U, Meier D, Bösiger P, Bassetti CL. 2009. Evidence for metabolic hypothalamo-amygdalo dysfunction in narcolepsy. Sleep Med 32, no. 5 (May): 607-613.
     

  81. Poryazova R, Werth E, Bassetti CL, Khatami R. 2009. Hypersomnia, REM sleep fragmentation and loss of motivation in a patient with hypothalamic lesions. Sleep Med 10, no. 7 (August): 812-813.
     

  82. Rancoita PMV, Hutter M, Bertoni F, Kwee I. 2009. Bayesian DNA copy number analysis. BMC Bioinformatics 10, no. 10 (January). 
     

  83. Reali L, Zuliani E, Gabutti L, Schönholzer C, Marone C. 2009. Poor oral hygiene enhances gingival overgrowth caused by calcineurin inhibitors. J Clin Pharm Ther 34, no. 3 (June): 255-260. 
     

  84. Rex J, Paradelo C, Mangas C, Hilari JM, Fernández-Figueras MT, Ferrándiz C. 2009.  Management of primary cutaneous melanoma of the hands and feet: a clinicoprognostic study. Ann Surg Oncol 35, no. 10 (October): 1505-1513.
     

  85. Rotger M, Bayard C, Taffé P, Martinez R, Cavassini M, Bernasconi E, Battegay M, Hirschel B, Furrer H, Witteck A, Weber R, Ledergerber B, Telenti A, Tarr PE, and the Swiss HIV Cohort Study. 2009. Contribution of genome-wide significant single nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals – a longitudinal study. Circ Cardiovasc Genet 2, no. 6 (December): 612-628.
     
  86. Rossi R, Rasi S, Franceschetti S, Capello D, Castelli A, De Paoli L, Ramponi A, Chiappella A, Pogliani EM, Vitolo U, Kwee I, Bertoni F, Conconi A, Gaidano G. 2009. Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21. Leukemia 23, no. 6 (June): 1118-1126.
     
  87. Rossi D, Sozzi E, Puma A, De Paoli L, Rasi S, Spina V, Gozzetti A, Tassi M, Cencini E, Raspadori D, Pinto V, Bertoni F, Gattei V,  Lauria F, Gaidano G, Forconi F. 2009. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. British Journal Haematology 146, no. 1 (June): 64-75.
     
  88. Rossi D, Spina V, Cerri M, Rasi S, Deambrogi C, De Paoli L, Laurenti L, Maffei R, Forconi F, Bertoni F, Zucca E, Agostinelli C, Cabras A, Lucioni M, Martini M, Magni M, Deaglio S, Ladetto M, Nomdedeu J, Besson C, Ramponi A, Canzonieri V, Paulli M, Marasca R, Larocca LM, Carbone A, Pileri SA, Gattei V, Gaidano G. 2009. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clinical Cancer Research 15, no. 13 (July): 4415-4422.
     
  89. Sartore-Bianchi A, Martini M, Molinari F, Veronese S, Nichelatti M, Artale S, Di Nicolantonio F, Saletti P, De Dosso S, Mazzucchelli L, Frattini M, Siena S, Bardelli A. 2009. PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies. Cancer Res 69, no. 5 (March): 1851-1857.
     
  90. Scotti C, Wirz D, Wolf F, Schaefer D J, Bürgin V, Daniels A U, Valderrabano V, Candrian C, Jakob M, Martin I, Barbero A. 2009. Engineering human cell-based, functionally integrated osteochondral grafts by biological bonding of engineered cartilage tissues to bony scaffolds. Biomaterials 31, no. 8 (March): 2252-2259.
     
  91. Sessa C, Cresta S, Noberasco C, Capri G, Gallerani E, De Braud F, Zucchetti M, D’Incalci M, Locatelli A, Marsoni S, Corradino I, Minoia C, Zintl P, Gianni L. 2009. Phase I clinical and pharmacokinetic study of trabectedin and cisplatin in solid tumours. Eur J Cancer 45, no. 12 (August): 2116-2122.
     
  92. Sessa C, Perotti A, Nobersco C, Braud F, Gallerani E, Cresta S, Zucchetti M, Viganò L, Locatelli A, Jimeno J, Feilchenfeldt JW, D'Incalci M, Capri G, lelmini N, Gianni L. 2009. Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and brast cancer. Eur J Cancer 45, no. 7 (May): 1153-1161. 
     
  93. Sessa C, Tosi D, Viganò L, Albanell J, Hess D, Maur M, Cresta S, Locatelli A, Angst R, Rojo F, Coceani N, Rivera V M, Berk L, Haluska F, and Gianni L. 2009. Phase Ib study of weekly mammalian Target of Rapamycin inhibitor Ridaforolimus (AP23573; MK-8669) with weekly paclitaxel. Ann Oncol 21, no. 6 (June): 1315-1322.
     
  94. Simonetti GD, Casaulta C, Vuissoz JM, Bianchetti MG, Nuoffer JM. 2009. Recurrent unexplained episodes of facial cyanosis and shortness of breath in Hunter disease. J Pediatr 155, no. 1 (July): 144, 144.e1.
     
  95. Stathis A, Chini C, Bertoni F, Proserpio I, Capella C, Mazzucchelli L, Pedrinis E, Cavalli F, Pinotti G, Zucca E. 2009. Long-term outcome following Helicobacter pylori eradication in a retrospectiove study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Ann Oncol 20, no. 6 (June): 1086-1093.
     
  96. Stolz D, Smyrnios N, Eggimann P, Pargger H, Thakkar N, Siegemund M, Marsch S, Azzola A, Rakic J, Mueller B, Tamm M. 2009. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J 34, no. 6 (December): 1364-1375.
     
  97. Tibiletti MG, Martin V, Bernasconi B, Del Curto B, Pecciarini L, Uccella S, Pruneri G, Ponzoni M, Mazzucchelli L, Martinelli G, Ferreri A, Pinotti G,Assannelli A, Scandurra M,  Doglioni C, Zucca E, Capella C, Bertoni F. BCL2, BCL6, MYC, MALT1 and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of FISH probes and correlation with clinical outcome. Human Pathology 40, no. 5 (May): 645-652.
     
  98. Truijers M, Resch T, van den Berg JC, Blankensteijn JD, Lonn L. 2009. Endovascular aneurysm repair: state-of-art imaging techniques for pre-operative planning and surveillance. J Cardiovasc Surg 50, no. 4 (August): 423-438.
     
  99. Valko P, Marti I, Werth E, Bassetti CL, Baumann HR. 2009. Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome. Sleep Med 10, no. 10 (December): 1146-1150.
     
  100. Valko PO, Sicccoli MM, Bassetti CL. 2009. Unilateral restless legs syndrome with predominantly ipsilateral PLMS and variable response to dopaminergic drugs: a variant of idiopathic RLS? Eur Journal of Neurology 16, no. 3 (March): 430-432.
     
  101. van den Berg JC. 2009. Carotid artery stenting: still alive? J Cardiovasc Surg 50, no. 6 (December): 713-714.
     
  102. Vandoni RE, Guerra A, Sanna P, Bogen M, Cavalli F, Gertsch P. 2009. Randomised comparison of complications from three different permanent central venous access systems. Swiss Med Wkly 139, no. 21-22 (May): 313-316.
      
  103. Viale G, Rotmensz N, Maisonneuve P, Bottiglieri L, Montagna E, Luini A, Veronesi P, Intra M, Torrisi R, Cardillo A, Campagnoli E, Goldhirsch A, Colleoni M. 2009. Invasive ductal carcinoma of the breast with the «triple-negative» phenotype: prognostic implications of EGFR immunoreactivity. Breast Cancer Res Treat 116, no. 2 (July): 317-328.
      
  104. Viale G, Rotmensz N, Maisonneuve P, Orvieto E, Maiorano E, Galimberti V, Luini A, Colleoni M, Goldhirsch A, Coates AS. 2009. Lack of prognostic significance of “classic” lobular breast carcinoma: a matched, single institution series. Breast Cancer Res Treat 117, no. 1 (September): 211-214.
     

  105. Vidal L, Gafter-Gvili A, Leibovici L, Dreyling M, Ghielmini M, Hsu Schmitz SF, Cohen A, Shpilberg O. 2009. Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials. J Natl Cancer Inst 101, no. 4 (February): 248-255.
     

  106. Vos JA, van Werkum MH, Bistervels JH, Ackerstaff RGA, Tromp SC, van den Berg JC. 2009. Retinal Embolization During Carotid Angioplasty and Stenting: Periprocedural Data and Follow-Up. Cardiovasc Intervent Radiol 33, no. 4 (August): 714-719.

      
  107. Wannesson L, Chigrinova E, Raditchkova M, Mazzucchelli L, Ghielmini M. 2009. Peliosis hepatis in cancer patients mimicking infection and metastases. Onkologie 32, no. 1-2 (February): 54-56.
     
  108. Weber R, Huber M, Rickenbach M, Furrer H, Elzi L, Hirschel B, Cavassini M, Bernasconi E, Schmid P, Ledergerber B, and the Swiss HIV Cohort Study. 2009. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study. HIV Med 10, no. 7 (August): 407-416.
     
  109. Wohlrab G, Leiba H, Kästle R, Ramelli GP, Schmitt-Mechelke T, Schmitt B, Landau K. 2009. Vigabatrin therapy in infantile spasms: solving one problem and inducing another? Epilepsia 50, no. 8 (August): 2006-2008.
     
  110. Wyttenbach R, Santini P, Moccetti M, Gallino A, Previsdomini M, Corti R. 2009. Response to letter regarding article: Posttraumatic Cardiac contrecoup: in vivo evidence by cardiac magnetic resonance imaging. Circulation 120: e156. 
     
  111. Young J, Bucher HC, Guenthard HF, Rickenbach M, Fux CA, Hirschel B, Cavassini M, Vernazza P, Bernasconi E, Battegay M and the Swiss HIV Cohort Study. 2009. Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV. Antiviral Therapy 14 (6): 771-779.
     
  112. Young J, Glass TR, Bernasconi E, Rickenbach M, Furrer H, Hirschel B, Tarr P, Vernazza P, Battegay M, Bucher HC and the Swiss HIV Cohort Study. 2009. Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy. J Clin Epidemiol 62, no. 6 (June): 632-641.
     

  113. Zecca C, Nessi F, Bernasconi E, Gobbi C. 2009. Ocular toxoplasmosis during natalizumab treatment. Neurology 73, no. 17 (October): 1418-1419.
     

  114. Zenhausern R, Schmitz SF, Solenthaler M, Heim D, Meyer-Monard S, Hess U, Leoncini L, Bargetzi M, Rufener B, Tobler A. 2009. Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (sakk 32/98). Leuk Lymphoma 50, no. 9 (September): 1501-1511.
     

  115. Zenhausern R, Von Rohr A, Rufibach K, Solenthaler M, Meyer-Monard S, Gratwohl A, Hess U, Bargetzi MJ, Kovacsovic T, Leoncini L, Tobler A. 2009. Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia - a multicentre trial SAKK 32/95. Leuk Lymphoma 16, no. 1 (January): 133-136.